C. Thompson

Anti cytokine therapy in chronic inflammatory arthritis.

E. Choy, R. Davies, C. Thompson, 2016, Cytokine.

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

R. Moots, P. McKeigue, J. Isaacs, 2022, Nature Medicine.

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

R. Moots, J. Isaacs, P. Sasieni, 2021, The Lancet.

The role of interleukin-6 trans-signalling on cardiovascular dysfunction in inflammatory arthritis

S. Rose-John, Simon A. Jones, E. Choy, 2020, Rheumatology.

CD28− Cells Are Increased in Early Rheumatoid Arthritis and Are Linked With Cytomegalovirus Status

E. Choy, Gareth W. Jones, R. Davies, 2020, Frontiers in Medicine.

Peripheral regulatory CD8+CD28-KLRG1+ T cells as markers of disease and treatment response in rheumatoid arthritis.

G. Jones, A. Williams, C. Greenhill, 2020, medRxiv.